India Glycols Q4 Results 2026: Date, Revenue, PAT And Analyst Outlook
Fri Apr 17 2026
India Glycols (NSE: INDIAGLYCO) is set to announce its Q4 FY26 (January–March 2026) results on May 10, 2026. Trading at Rs 680 as of April 2026 — down -35% from its 52-week high of Rs 1,050 — the stock enters this pivotal results event having already corrected meaningfully from peak levels. Q4 FY26 delivers the full-year FY26 performance and the first formal FY27 management guidance.
This preview covers the confirmed results date, analyst consensus estimates, five key performance factors, five risks to monitor, analyst ratings, and the complete share price outlook for India Glycols ahead of Q4 FY26 results.
Get free investment predictions from SEBI-registered analysts on Univest.
India Glycols Q4 Results 2026 Date
The India Glycols Q4 FY26 results date is May 10, 2026. The board will approve Q4 and full-year FY26 financial results, consider a final dividend for FY26, and provide management’s first formal FY27 business outlook.
| Company | Q4 Results Date | Key Metric to Watch |
| TCS | April 9, 2026 (Declared) | FY27 CC guidance + deal TCV |
| Infosys | April 23, 2026 | CC revenue growth range |
| HCL Technologies | April 22, 2026 | CC growth + EBIT margin |
| HDFC Bank | April 19, 2026 | NIM recovery + loan growth |
| India Glycols | May 10, 2026 | See estimates below |
Why Q4 FY26 Matters
Q4 FY26 is the final quarter of FY2025–26 and carries the highest informational weight of any quarterly result. Beyond the Q4 standalone performance, the India Glycols board on May 10, 2026 will deliver the complete FY26 annual performance, a final dividend recommendation, and the first formal FY27 guidance commentary — making this the single most important quarterly event for India Glycols investors.
For India Glycols in the Specialty Chemicals / Glycols / ENA sector, Q4 captures the peak-season demand dynamics that typically deliver the quarter’s strongest operating leverage when execution conditions are favourable.
India Glycols Q4 FY26 Earnings Estimates
Access premium analyst research on Univest.
| Metric | Q4 FY26 Estimate | Q3 FY26 Actual | Trend |
| Revenue | Rs 1,800 Cr | Rs 1,636 Cr | Sequential improvement expected |
| Net Profit (PAT) | Rs 48 Cr | Rs 44 Cr | Normalisation in progress |
| Operating Margin | EBITDA 8% | Q3 FY26 level | Stable to improving |
| Volume / Revenue Growth | +8% volume YoY | Prior quarter | YoY improvement expected |
| Final Dividend (Expected) | Rs 2 | FY26 interim dividends | Board decision on May 10, 2026 |
Screen India Glycols live on the Univest Screener — real-time fundamentals, FII/DII flows, and analyst ratings.
Download the Univest iOS App or Univest Android App for live Q4 result alerts.
5 Key Factors Driving India Glycols Q4 FY26 Performance
1. Specialty Chemical Export Recovery
Global destocking approaching resolution. FY27 export recovery expected as buyer inventory normalises.
2. Domestic Industrial Demand
Manufacturing growth in auto, pharma, textiles drives domestic industrial chemical consumption.
3. Import Substitution
PLI schemes and Make in India create domestic demand for chemicals previously imported from China.
4. Raw Material Management
Petroleum derivative and natural gas input costs determine gross margin trajectory.
5. New Product Launches
New specialty molecule registrations expand addressable market and improve realisation.
5 Risks to Watch in India Glycols Q4 FY26
Risk 1: Input Cost Volatility
Raw material and input cost changes can compress margins unexpectedly.
Risk 2: Revenue Concentration Risk
Customer or geographic concentration creates quarterly variance.
Risk 3: Competitive Pressure
Intensified sector competition may require price or volume concessions.
Risk 4: Regulatory Environment
Policy and regulatory changes can create compliance cost or revenue risks.
Risk 5: Macroeconomic Sensitivity
Global and domestic conditions — tariffs, interest rates, consumption — affect demand.
India Glycols Share Price and Analyst Ratings
| Parameter | Value |
| CMP (April 2026) | Rs 680 |
| 52-Week High | Rs 1,050 |
| 52-Week Low | Rs 598 |
| 1-Year Return | -35% |
| Market Cap | Rs 2,800 Cr |
| Sector | Specialty Chemicals / Glycols / ENA |
| NSE Ticker | INDIAGLYCO |
| Q4 Results Date | May 10, 2026 |
| Brokerage | Rating | Thesis Summary |
| Motilal Oswal | BUY | Q4 recovery potential; sector tailwinds intact |
| YES Securities | ADD | Earnings inflection expected; FY27 guidance key |
| Kotak Institutional | NEUTRAL | Fair valued at current levels; execution key |
Conclusion
India Glycols Q4 FY26 results on May 10, 2026 will be the most important quarterly event of FY26. At Rs 680 — down -35% from its 52-week high of Rs 1,050 — the stock has already priced in significant headwinds. Revenue above Rs 1,800 Cr with EBITDA 8% would constitute a beat versus analyst consensus. Management’s FY27 guidance is the primary re-rating catalyst that determines whether the current level represents an entry opportunity.
Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All data sourced from publicly available information. Verify before investing. Consult a SEBI-registered financial advisor before making investment decisions.
For more Q4 FY26 results previews, visit Univest Blogs.
Frequently Asked Questions
Q: When is India Glycols Q4 results 2026 date?
India Glycols Q4 FY26 results date is May 10, 2026. The board will approve the audited Q4 and full-year FY26 financial results, consider a final dividend, and provide FY27 guidance.
Q: What is India Glycols Q4 FY26 revenue estimate?
Analyst consensus Q4 FY26 revenue estimate for India Glycols is Rs 1,800 Cr. Q3 FY26 actual revenue was Rs 1,636 Cr. Actual results may differ based on operating conditions.
Q: What is India Glycols share price ahead of Q4 results?
India Glycols trades at Rs 680 as of April 2026. 52-week high is Rs 1,050; 52-week low is Rs 598. 1-year return is -35%. Market cap is Rs 2,800 Cr.
Q: Will India Glycols declare a dividend in Q4 2026?
India Glycols is expected to declare Rs 2 as final dividend for FY26, subject to board approval on May 10, 2026 and subsequent AGM shareholder approval.
Q: Which analysts have a Buy rating on India Glycols?
Motilal Oswal has a BUY rating and YES Securities has an ADD rating on India Glycols based on publicly available research. Check the Univest Screener for the latest analyst ratings.
Q: What were India Glycols Q3 FY26 results?
India Glycols reported Q3 FY26 revenue of Rs 1,636 Cr and PAT of Rs 44 Cr. The Q4 FY26 results on May 10, 2026 provide the full-year FY26 comparison and first FY27 guidance.
Q: When do TCS and Infosys announce Q4 results 2026?
TCS declared Q4 FY26 results on April 9, 2026. HCL Technologies declared on April 22. HDFC Bank declared on April 19. Infosys Q4 FY26 results are scheduled for April 23, 2026.
Q: Is India Glycols a good investment ahead of Q4 results?
This article does not constitute investment advice. India Glycols trades at Rs 680 — down -35% from its peak. Analyst consensus Q4 revenue estimate is Rs 1,800 Cr and PAT estimate is Rs 48 Cr. Review the five factors and five risks above. Consult a SEBI-registered financial advisor before investing.
Recent Article
Chembond Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Chambal Fertilizers & Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Chaman Lal Setia Exports Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Chalet Hotels Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Cerebra Integrated Technologies Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
